Information Library
Brochures - Phase IIIB/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
What if You Could Expect More from Late Phase
October 1, 2009
Quintiles and Cerner share how you can get more from your late phase efforts. -
Clinical Development Services
June 18, 2009
Find out how large pharmaceutical companies and emerging biotech move products past each development milestone. -
Leveraging Patient-Reported Outcomes Prior to Comparative Effectiveness Studies
June 18, 2009
Leveraging Patient-Reported Outcome Methods to Test Hypotheses Prior to Initiating Comparative Effectiveness Studies -
Oversight Group Management Services
April 16, 2009
Quintiles provides a high level of experience, expertise and customer service to the entire clinical trial process. This is especially true for the oversight group management service, known as CEVA. -
Risk Mitigation Programs
April 16, 2009
Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance. -
Risk Assessment & Strategy
April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
Phase IIIb/IV Studies
April 16, 2009
New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies. -
Late Phase and Safety Services
April 10, 2009
Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread. -
Badania Kliniczne
April 10, 2009
Quintiles Poland świadczy usługi związane z organizacją i monitorowaniem Badań Klinicznych faz I-IV. Każdy nowy lek - zanim będzie dostępny w sprzedaży- musi przejść fazę wszechstronnych, specjalistycznych testów i uzyskać aprobatę organów rejestracyjnych. -
Hungary
March 27, 2009
A Quintiles 1998 óta mûködik Magyarországon. Tagja a világ legnagyobb, legsikeresebb klinikai kutatási szerzõdéses vállalatcsoportjának, a Quintiles Transnational-nek. A Quintiles Transnational több mint 19.000 alkalmazottat foglalkoztat a világ több mint 50 országában.